Shah Nirav R, Hirsch Annemarie G, Zacker Christopher, Taylor Scott, Wood G Craig, Stewart Walter F
Center for Health Research, Geisinger Clinic, Danville, PA 17822, USA.
J Gen Intern Med. 2009 Feb;24(2):233-7. doi: 10.1007/s11606-008-0870-z. Epub 2008 Dec 17.
Little is known about first-fill adherence rates for diabetic medications and factors associated with non-fill.
To assess the proportion of patients who fill their initial prescription for a diabetes medication, understand characteristics associated with prescription first-fill rates, and examine the effect of first-fill rates on subsequent A1c levels.
Retrospective, cohort study linking electronic health records and pharmacy claims.
One thousand one hundred thirty-two patients over the age of 18 who sought care from the Geisinger Clinic, had Geisinger Health Plan pharmacy benefits, and were prescribed a diabetes medication for the first time between 2002 and 2006.
The primary outcome of interest was naïve prescription filled by the patient within 30 days of the prescription order date.
The overall first-fill adherence rate for antidiabetic drugs was 85%. Copays < $10 (OR 2.22, 95% CI 1.57-3.14) and baseline A1c > 9% (OR 2.63, 95% CI 1.35, 5.09) were associated with improved first-fill rates while sex, age, and co-morbidity score had no association. A1c levels decreased among both filling and non-filling patients though significantly greater reductions were observed among filling patients. Biguanides and sulfonylureas had higher first-fill rates than second-line oral agents or insulin.
First-fill rates for diabetes medication have room for improvement. Several factors that predict non-filling are readily identifiable and should be considered as possible targets for interventions.
关于糖尿病药物首次配药依从率以及与未配药相关的因素,人们了解甚少。
评估首次开具糖尿病药物处方的患者配药比例,了解与处方首次配药率相关的特征,并研究首次配药率对后续糖化血红蛋白(A1c)水平的影响。
将电子健康记录与药房报销数据相联系的回顾性队列研究。
1132名年龄在18岁以上的患者,他们在盖辛格诊所就诊,享受盖辛格健康计划药房福利,并于2002年至2006年期间首次被开具糖尿病药物处方。
主要关注的结果是患者在处方开具日期后的30天内配药。
抗糖尿病药物的总体首次配药依从率为85%。自付费用低于10美元(比值比[OR]为2.22,95%置信区间[CI]为1.57 - 3.14)以及基线糖化血红蛋白水平>9%(OR为2.63,95% CI为1.35,5.09)与首次配药率提高相关,而性别、年龄和合并症评分则无关联。无论配药与否,患者的糖化血红蛋白水平均有所下降,但配药患者的下降幅度明显更大。双胍类药物和磺脲类药物的首次配药率高于二线口服药物或胰岛素。
糖尿病药物的首次配药率有提升空间。一些可预测未配药情况的因素易于识别,应被视为可能的干预目标。